Navigate peer-reviewed breakthroughs by pharmacological class, genetic target, circulating biomarker, or diagnostic modality. Select any clinical entity to inspect all linked studies.
Everyday Health & Science Hubs
Indexed Entities (24)
Drug / Therapy8 Peer-Reviewed Briefings
Neuropsychiatric & Synaptic Therapeutics
Rapid-acting antidepressants, serotonergic/glutamatergic modulators, and neuromodulation protocols.
Daily consumption of 2-3 cups of caffeinated coffee is strongly associated with a dramatically lower long-term risk of dementia and better cognitive function, independently of genetic predisposition. Dementia currently lacks effective preventative pharmacological interventions, making lifestyle modifications a cornerstone of risk reduction strategies.
3/5 Observational
Evidence Meter · 3/5
Real-World Observation
Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.
Psilocybin rapidly induces neuroplasticity, repairing stress-damaged brain circuits, and future therapeutic strategies may harness this effect without the associated psychedelic experience. Current pharmacological interventions for chronic stress-related disorders, such as major depressive disorder (MDD) and post-traumatic stress disorder (PTSD), often have a delayed onset of action (weeks to months) and achieve remission in only a fraction of patients.
2/5 Preclinical
Evidence Meter · 2/5
Animal & Preclinical Data
Demonstrated in living animal models before large-scale human safety and dosing trials begin.
Clomipramine showed the largest estimated efficacy (real-world effectiveness in the trial) for obsessive-compulsive disorder but had a lower tolerability than SSRIs. The evidence of its superiority over individual SSRIs was more pronounced in children and adolescents.
5/5 Gold Standard
Evidence Meter · 5/5
Gold-Standard Human Evidence
Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.
Antidepressants can differ in their efficacy (real-world effectiveness in the trial) for achieving sustained response and in their acceptability. These findings can inform the shared decision making for patients, prescribers, and carers in real-world practice.
5/5 Gold Standard
Evidence Meter · 5/5
Gold-Standard Human Evidence
Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.
This study provides first longitudinal evidence of regionally coordinated DNA methylation changes during antidepressant pharmacotherapy, revealing alterations in genes involved in neuroplasticity and inflammatory processes that are associated with clinical response. Baseline methylation levels were associated with depressive symptom severity at day 28 and day 56 through two and six DMRs, respectively (e.g., TNRC6C, CAT), whereas no single DMP reached significance.
3/5 Observational
Evidence Meter · 3/5
Real-World Observation
Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.
This exploratory trial did not provide statistically robust evidence that concurrent complex cognitive engagement enhanced the acute working-memory effects of IPL-targeted 10-Hz rTMS in euthymic bipolar II disorder, suggesting that task type, cognitive load, and stimulation-task coupling warrant further systematic optimization in future neuromodulation studies. Repetitive transcranial magnetic stimulation (rTMS) is a promising neuromodulatory approach for cognitive improvement in psychiatric disorders.
5/5 Gold Standard
Evidence Meter · 5/5
Gold-Standard Human Evidence
Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.
Together, these findings suggest that filamin-A-dependent cytoskeletal stress acts as an upstream molecular context in which immediate early gene-centred transcriptional dysregulation emerges and becomes linked to dopaminergic vulnerability in progressive supranuclear palsy. Multi-layered analyses revealed cortical monoamine depletion together with early striatal dopaminergic sensitization, indicating a close association between immediate early gene dysregulation and dopaminergic circuit imbalance.
2/5 Preclinical
Evidence Meter · 2/5
Animal & Preclinical Data
Demonstrated in living animal models before large-scale human safety and dosing trials begin.
Results of this quasi-experimental difference-in-differences study suggest that online sports betting legalization was associated with an increase in outpatient and prescription mental health care use among people with employer-sponsored health insurance. These findings underscore the importance of prevention and treatment of potential adverse health consequences of legalized online sports betting.
3/5 Observational
Evidence Meter · 3/5
Real-World Observation
Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.
1 min read·JAMA Psychiatry·
Patient & Student Companion
Everyday Lab & Drug Translator
Instant plain-English guides for common blood tests and prescriptions—what normal ranges mean, what high/low values signal, and what to ask your clinician.
Lab Marker3-Month Blood Sugar
HbA1c
Measures the percentage of red blood cell hemoglobin coated with glucose over roughly 90 days.
Normal: below 5.7% · Prediabetes: 5.7%–6.4%
6.5% or higher on two tests diagnoses diabetes; very low values can occur alongside hypoglycemia or hemolytic anemia.
Ask your doctor: “Does my HbA1c match my daily fasting/post-meal glucose trends?”
Estimated glomerular filtration rate—how many milliliters of blood your kidneys filter every minute.
Healthy adult filter rate: 90+ mL/min/1.73m²
Values persistently below 60 for 3+ months (or elevated urine albumin) mark chronic kidney disease; single dips can simply reflect dehydration or NSAID use.
Ask your doctor: “Should we pair eGFR with a urine albumin-to-creatinine test (uACR)?”